Search
for
Sort by
Research 61–90 of 186
- Antiandrogens
- Hormone therapy for transgender patients
- Endocrinology of Transgender Medicine
- Hair Growth Promotion Activity and Its Mechanism of<i>Polygonum multiflorum</i>
- Cross-sex hormone therapy for gender dysphoria
- Pantolactams as androgen receptor antagonists for the topical suppression of sebum production
- Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated Flutamide using LC-MS and GC-MS Spectrometry
- Introduction
- Bicalutamide does not raise transaminases in comparison to alternative anti-androgen regimens among transfeminine adolescents and young adults: a retrospective cohort study
- Contents
- The Role of the Orthognathic Surgeon in Facial Feminization Surgery
- Enhanced Follicular Delivery of Finasteride to Human Scalp Skin Using Heat and Chemical Penetration Enhancers
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7
- The Biology of Hair Follicles
- Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- Hair Loss in Women
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Physiology of the Hypothalamic Pituitary Gonadal Axis in the Male
- Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review
- Idiopathic Hirsutism*
- Hair growth effects of oral administration of finasteride, a steroid 5 alpha-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque.
- Understanding and Addressing Hair Disorders in Transgender Individuals
- Adolescent hair loss
- Relative Safety and Efficacy of Finasteride for Treatment of Hirsutism
- Post-finasteride syndrome: An emerging clinical problem
- Hormonal and Surgical Treatment Options for Transgender Men (Female-to-Male)
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Considerations in genetic counseling of transgender patients: Cultural competencies and altered disease risk profiles